MILPHARM LIMITED — The Accounts

Get an alert when MILPHARM LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Next accounts due

2026-12-31 (in 7mo)

Last filed for 2025-03-31

Confirmation statement due

2026-06-03 (in 1mo)

Last made up 2025-05-20

Watchouts

None on the register

Cash

£73M

+47.5% highest in 4 filed years

Net assets

£38M

+9.2% highest in 4 filed years

Employees

+8.8% highest in 4 filed years

Profit before tax

£7M

-11.9% vs 2024

Net assets

5-year trend · vs Consumer Discretionary median

MILPHARM LIMITED·Consumer Discretionary median · n=10325

Accounts

5-year trend · latest reflected 2025-03-31

Metric	2019-03-31	2020-03-31	2021-03-31	2024-03-31	2025-03-31
Turnover	—	£64,809,436	£77,568,089	£65,816,437	£66,210,783
Operating profit	—	£4,541,994	£6,490,661	£6,772,855	£5,601,381
Profit before tax	—	£4,542,172	£6,490,536	£8,215,632	£7,237,168
Net profit	—	£3,664,065	£5,255,431	£6,159,468	£5,425,162
Cash	—	£4,855,077	£6,008,333	£49,300,424	£72,706,843
Total assets less current liabilities	—	£16,563,035	£21,297,121	£34,658,335	£37,735,371
Net assets	—	£16,328,270	£21,083,701	£34,448,793	£37,607,019
Equity	£12,664,205	£16,328,270	£21,083,701	£34,448,793	£37,607,019
Average employees	—	38	44	57	62
Wages	—	£3,045,084	£3,914,246	£3,917,927	£4,642,940
Directors' remuneration	—	£842,504	£923,498	£1,239,475	£896,887

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Year-on-year

FY2024 → FY2025 · period ending 2025-03-31 vs 2024-03-31

Turnover

+0.6%

£65,816,437 £66,210,783
Cash

+47.5%

£49,300,424 £72,706,843

highest in 4 filed years
Net assets

+9.2%

£34,448,793 £37,607,019

highest in 4 filed years
Employees

+8.8%

57 62

highest in 4 filed years
Operating profit

-17.3%

£6,772,855 £5,601,381
Profit before tax

-11.9%

£8,215,632 £7,237,168
Wages

+18.5%

£3,917,927 £4,642,940

highest in 4 filed years

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio	2019-03-31	2020-03-31	2021-03-31	2024-03-31	2025-03-31
Operating margin	—	7.0%	8.4%	10.3%	8.5%
Net margin	—	5.7%	6.8%	9.4%	8.2%
Return on capital employed	—	27.4%	30.5%	19.5%	14.8%
Current ratio	—	—	—	1.69x	1.54x
Interest cover	—	—	4977.50x	7.36x	4.26x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis: FRS 102
Reporting scope: Standalone (parent only)
Auditor: The Corporate Practice Limited
Audit opinion: Unqualified (clean)
Going concern: Affirmed
“After reviewing the Company forecasts and working capital requirements, the directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future, being a period of not less than twelve months from the date of approval of these financial statements. The Company therefore continues to adopt the going concern basis in preparing its financial statements.”

Significant events

“Current global crisis i.e. Ukraine/Russia/India/Pakistan, Tarriff by US, Oil & Energy price increase, higher Inflation factor have severely impacted most economies around the globe.”
“During FY25 the market dynamics changed due to product availability and other driving factors.”
“Milpharm Limited managed to maintain reasonable stock levels in view of those situations related requirements. Sufficient stock levels will be maintained in FY26 and continuously monitored.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

3 active · 23 resigned

Name	Role	Appointed	Born	Nationality
MURALIDHARAN, Venugopalan, Mr.	Director	2011-06-06	Dec 1955	British
VENKATRAMAN, Baskar	Director	2022-08-31	Dec 1962	American
WILLIAMS, Kevin	Director	2025-01-01	Aug 1978	British

Show 23 resigned officers

Name	Role	Appointed	Resigned
HARRIS, Colin Michael	Secretary	1997-04-11	1997-10-01
RATTAN, Bhagwant Singh	Secretary	1997-10-01	2006-02-09
SOBTI, Parminder	Secretary	2011-02-17	2014-05-20
THOGARCHEDU, Srikanth	Secretary	2006-02-09	2011-02-17
HALLMARK SECRETARIES LIMITED	Corporate Nominee Secretary	1997-04-11	1997-04-11
ATTUR, Sreesha	Director	2006-08-16	2007-08-16
BROEER, Thomas	Director	2017-01-11	2024-03-14
GORLA, Phaneemdra Prasad	Director	2007-08-16	2012-06-01
HARRIS, Colin Michael	Director	1997-10-01	2000-09-29
JOHNSON, Christopher Paul	Director	2012-06-01	2017-02-22
MURALIDHARAN, Venugopalan	Director	2006-02-09	2006-03-30
PENAKA, Venkata Ramprasad Reddy	Director	2006-03-30	2007-08-16
PRAKASH, Manoj	Director	2015-03-20	2018-02-20
PRASAD, Gorla Phaneemdra	Director	2014-09-01	2022-08-31
RATTAN, Bhagwant Singh	Director	2006-02-09	2007-08-16
RATTAN, Bhagwant Singh	Director	2000-01-01	2006-02-09
SHARMA, Anil Kumar	Director	2001-10-01	2006-02-09
SINGHI, Sudhir Babumal	Director	2007-08-16	2012-06-01
SWAIN, Avinash Chandra	Director	2012-06-01	2017-09-12
SYLVESTER-WILLIAMS, Innes	Director	2007-07-26	2010-03-09
THOGARCHEDU, Srikanth	Director	2006-02-09	2006-03-30
WHYTE, Melvyn Mark	Director	1997-04-11	2006-02-09
HALLMARK REGISTRARS LIMITED	Corporate Nominee Director	1997-04-11	1997-04-11

Ownership

Persons with significant control

Name	Kind	Nature of control	Notified	Status
Agile Pharma B.V.	Corporate entity	Shares 75–100%	2016-04-06	Active

Filing timeline

Last 20 of 129 total filings

Date	Type	Category	Description
2025-11-03	AD01	address	Change registered office address company with date old address new address	PDF
2025-10-22	AD01	address	Change registered office address company with date old address new address	PDF
2025-10-14	CH01	officers	Change person director company with change date	PDF
2025-10-14	CH01	officers	Change person director company with change date	PDF
2025-07-21	AA	accounts	Accounts with accounts type full
2025-05-20	CS01	confirmation-statement	Confirmation statement with no updates	PDF
2025-03-07	AP01	officers	Appoint person director company with name date	PDF
2024-09-02	AA	accounts	Accounts with accounts type full
2024-05-20	CS01	confirmation-statement	Confirmation statement with no updates	PDF
2024-03-14	TM01	officers	Termination director company with name termination date	PDF
2023-07-24	AA	accounts	Accounts with accounts type full
2023-06-01	CS01	confirmation-statement	Confirmation statement with no updates	PDF
2022-09-15	AP01	officers	Appoint person director company with name date	PDF
2022-09-12	TM01	officers	Termination director company with name termination date
2022-07-19	AA	accounts	Accounts with accounts type full
2022-06-30	CS01	confirmation-statement	Confirmation statement with no updates	PDF
2021-06-29	CS01	confirmation-statement	Confirmation statement with no updates	PDF
2021-06-28	AA	accounts	Accounts with accounts type full	PDF
2021-01-28	AA	accounts	Accounts with accounts type full
2020-06-04	CS01	confirmation-statement	Confirmation statement with no updates	PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings: 6
Capital events: 0
Officers appointed: 0
Officers resigned: 0

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Official Companies House page